#MedTech #Ireland #Waterford #Schivo #Mecaplast

Schivo Acquisition of Mecaplast SA: A Smart Move for MedTech

In a strategic move that aims to bolster its manufacturing capabilities, Schivo, based in Waterford, Ireland, has announced the acquisition of Mecaplast SA, a Swiss company renowned for its high-precision injection-moulded components primarily used in the medical device and life sciences sectors. Founded in 1971 in Botterens, Switzerland, Mecaplast specializes in producing critical components and provides cleanroom assemblies and precision molds for some of the industry's leading original equipment manufacturers (OEMs).

The acquisition represents a significant expansion of Schivo's capabilities in precision plastics, metals, and ceramics, effectively enhancing its offerings in the MedTech and Life Sciences sectors. With a state-of-the-art facility that spans over 64,000 square feet and holds ISO 13485 certification, Mecaplast is equipped to address complex manufacturing needs. The company’s expertise extends to micro-molding, over-molding, and automation—technologies increasingly in demand for innovative medical applications.

Graham Reeves, CEO of Schivo, expressed optimism about the acquisition, stating, “Mecaplast brings decades of deep expertise in complex plastics, metals, and ceramics, perfectly aligning with our vision of creating a global, multi-capability platform for advanced medical and life sciences devices.” This acquisition will not only strengthen Schivo's vertical integration but will also create a new European center of excellence, allowing the company to enhance its injection molding capabilities across its operations in the U.S. and Mexico, thus providing better service for MedTech OEMs across key international markets.

Jean-Marc Jaccottet, CEO and Owner of Mecaplast, echoed similar sentiment regarding the two companies' alignment. He commented, “Joining Schivo represents a natural and exciting evolution for Mecaplast SA. Our team looks forward to serving our long-standing customers while also meeting the needs of new clients.” Jaccottet will now join Schivo's leadership team as the President of Molding Technologies, where he will lead research and development initiatives while driving the company's capacity growth.

With this acquisition, Schivo is better positioned to tackle unique engineering challenges, innovate manufacturing processes, and streamline the supply chain for clients in the medical and life sciences industries. Their objective is to not only develop and manufacture prototypes but to also see these innovations through to commercial production, allowing companies to rapidly bring their technologies to market.

In conclusion, Schivo's acquisition of Mecaplast SA is more than just a strategic expansion; it is a commitment to enhancing the quality and reliability of medical device production. This partnership underscores a shared vision for transforming the future of medical technology—one high-precision component at a time. As the industry evolves, such strategic collaborations will be pivotal for companies looking to lead and innovate within the highly competitive MedTech landscape.

For more information on Schivo's services and their new capabilities following the acquisition, visit Schivo Medical.